Form D · Other Technology
MedCurrent Corp
Toronto, A6 · CIK 0001640583
Offering snapshot reported Apr 27, 2015 · SEC filing
- Reported sold
- $221K Offering amount: $483K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 23, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 27, 2015 | Initial | $220,773 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-238714
Class A preferred shares and warrants; warrants exercisable for additional Class A preferred shares at Cdn$0.82; Class A preferred shares convertible into common stock.
Source: Form D, filed Apr 27, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel Duboc | Director |
| Bill Gula | Director |
| Stephen Herman | Director, Executive |
| Paul Lasiuk | Director |
| Jotinder Manget | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
40 Holly Street, Suite 300
Toronto, A6, M4S 3C3
Toronto, A6, M4S 3C3